{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:23:46Z","timestamp":1783661026763,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100020595","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2320-B-002-032-MY3"],"award-info":[{"award-number":["110-2320-B-002-032-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.dmd.2026.100273","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:02:10Z","timestamp":1773680530000},"page":"100273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gut microbial resistance and metabolism of selective serotonin reuptake inhibitors drive multidrug resistance and contribute to antidepressant tachyphylaxis"],"prefix":"10.1016","volume":"54","author":[{"given":"Ming-Che","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5642-4679","authenticated-orcid":false,"given":"Chia-Ching","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hsiu","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoei-Sheng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-9602","authenticated-orcid":false,"given":"Chia-Chuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl E1","key":"10.1016\/j.dmd.2026.100273_bib2","first-page":"4","article-title":"Relationship of neurotransmitters to the symptoms of major depressive disorder","volume":"69","author":"Nutt","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"10.1016\/j.dmd.2026.100273_bib3","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","article-title":"Dopamine system dysregulation in major depressive disorders","volume":"20","author":"Belujon","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"issue":"8","key":"10.1016\/j.dmd.2026.100273_bib4","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","article-title":"The serotonin theory of depression: a systematic umbrella review of the evidence","volume":"28","author":"Moncrieff","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"6","key":"10.1016\/j.dmd.2026.100273_bib5","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nsmb.1602","article-title":"Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures","volume":"16","author":"Zhou","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"10.1016\/j.dmd.2026.100273_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0165-0327(98)00221-3","article-title":"Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects","volume":"51","author":"Stahl","year":"1998","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41398-022-02285-2","article-title":"The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective","volume":"13","author":"Boschloo","year":"2023","journal-title":"Transl Psychiatry"},{"issue":"3-4","key":"10.1016\/j.dmd.2026.100273_bib8","first-page":"24","article-title":"Identification and treatment of antidepressant tachyphylaxis","volume":"11","author":"Targum","year":"2014","journal-title":"Innov Clin Neurosci"},{"issue":"5","key":"10.1016\/j.dmd.2026.100273_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1440-1819.2011.02231.x","article-title":"Tachyphylaxis\/tolerance to antidepressants in treatment of dysthymia: results of a retrospective naturalistic chart review study","volume":"65","author":"Katz","year":"2011","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.sxmr.2017.07.002","article-title":"Post-SSRI sexual dysfunction: a literature review","volume":"6","author":"Bala","year":"2018","journal-title":"Sex Med Rev"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12991-023-00447-0","article-title":"Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants","volume":"22","author":"Ben-Sheetrit","year":"2023","journal-title":"Ann Gen Psychiatry"},{"issue":"9","key":"10.1016\/j.dmd.2026.100273_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11920-017-0816-4","article-title":"Effects of antidepressants on sleep","volume":"19","author":"Wichniak","year":"2017","journal-title":"Curr Psychiatry Rep"},{"issue":"10","key":"10.1016\/j.dmd.2026.100273_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad177","article-title":"Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysis","volume":"46","author":"Zhou","year":"2023","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib14","first-page":"22","article-title":"SSRI antidepressant medications: adverse effects and tolerability","volume":"3","author":"Ferguson","year":"2001","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.dmd.2026.100273_bib15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2147\/TCRM.S363404","article-title":"Risks of digestive system side-effects of selective serotonin reuptake inhibitors in patients with depression: a network meta-analysis","volume":"18","author":"Wang","year":"2022","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.dmd.2026.100273_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110266","article-title":"Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: a systematic review and meta-analysis","volume":"109","author":"Oliva","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00248-022-02081-x","article-title":"Human gut microbiota and drug metabolism","volume":"86","author":"Pant","year":"2023","journal-title":"Microb Ecol"},{"issue":"7762","key":"10.1016\/j.dmd.2026.100273_bib18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/03602532.2020.1718691","article-title":"The metabolic effect of gut microbiota on drugs","volume":"52","author":"Xie","year":"2020","journal-title":"Drug Metab Rev"},{"issue":"2","key":"10.1016\/j.dmd.2026.100273_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tim.2021.12.003","article-title":"Bioaccumulation as a mechanism of microbiome\/drug interactions","volume":"30","author":"Cohen","year":"2022","journal-title":"Trends Microbiol"},{"issue":"7877","key":"10.1016\/j.dmd.2026.100273_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41586-021-03891-8","article-title":"Bioaccumulation of therapeutic drugs by human gut bacteria","volume":"597","author":"Kl\u00fcnemann","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/biomedicines12010194","article-title":"Mechanisms and clinical implications of human gut microbiota-drug interactions in the precision medicine era","volume":"12","author":"Wang","year":"2024","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.dmd.2026.100273_bib23","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-023-01619-w","article-title":"Drug-microbiota interactions: an emerging priority for precision medicine","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.dmd.2026.100273_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104163","article-title":"Gut microbiome in modulating immune checkpoint inhibitors","volume":"82","author":"Li","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.dmd.2026.100273_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.858126","article-title":"DeePred-BBB: a blood brain barrier permeability prediction model with improved accuracy","volume":"16","author":"Kumar","year":"2022","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib27","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41467-018-04059-1","article-title":"Evolution of high-level resistance during low-level antibiotic exposure","volume":"9","author":"Wistrand-Yuen","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.dmd.2026.100273_bib28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fmicb.2020.00233","article-title":"The impact of ackA, pta, and ackA-pta mutations on growth, gene expression and protein acetylation in Escherichia coli K-12","volume":"11","author":"Sch\u00fctze","year":"2020","journal-title":"Front Microbiol"},{"issue":"24","key":"10.1016\/j.dmd.2026.100273_bib29","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1128\/AEM.01546-07","article-title":"Improved succinic acid production in the anaerobic culture of an Escherichia coli pflB ldhA double mutant as a result of enhanced anaplerotic activities in the preceding aerobic culture","volume":"73","author":"Wu","year":"2007","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"10.1016\/j.dmd.2026.100273_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/metabo10040166","article-title":"metabolic engineering design strategies for increasing acetyl-CoA Flux","volume":"10","author":"Ku","year":"2020","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.dmd.2026.100273_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.dmd.2026.100273_bib32","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1574-6976.2011.00290.x","article-title":"Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria","volume":"36","author":"Nikaido","year":"2012","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/antibiotics12010180","article-title":"Update on the discovery of efflux pump inhibitors against critical priority Gram-negative bacteria","volume":"12","author":"Compagne","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"3","key":"10.1016\/j.dmd.2026.100273_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/pathogens13030197","article-title":"Types and mechanisms of efflux pump systems and the potential of efflux pump inhibitors in the restoration of antimicrobial susceptibility, with a special reference to Acinetobacter baumannii","volume":"13","author":"Zack","year":"2024","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.dmd.2026.100273_bib35","doi-asserted-by":"crossref","DOI":"10.1099\/mic.0.001307","article-title":"Tripartite efflux pumps of the RND superfamily: what did we learn from computational studies?","volume":"169","author":"Athar","year":"2023","journal-title":"Microbiology (Reading)"},{"issue":"3","key":"10.1016\/j.dmd.2026.100273_bib36","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jmb.2004.07.088","article-title":"Structure of the ligand-blocked periplasmic entrance of the bacterial multidrug efflux protein TolC","volume":"342","author":"Higgins","year":"2004","journal-title":"J Mol Biol"},{"issue":"2","key":"10.1016\/j.dmd.2026.100273_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/jac\/dki445","article-title":"Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli","volume":"57","author":"Kern","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.dmd.2026.100273_bib38","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1073\/pnas.98.4.1525","article-title":"Trapping the transition state of an ATP-binding cassette transporter: evidence for a concerted mechanism of maltose transport","volume":"98","author":"Chen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41467-021-27726-2","article-title":"Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps","volume":"13","author":"Pl\u00e9","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.dmd.2026.100273_bib40","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/jac\/dkl081","article-title":"Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide","volume":"57","author":"Pannek","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.dmd.2026.100273_bib41","first-page":"251","article-title":"ADME prediction with KNIME: in silico aqueous solubility consensus model based on supervised recursive random forest approaches","volume":"8","author":"Falc\u00f3n-Cano","year":"2020","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.dmd.2026.100273_bib42","article-title":"Using read-across to build physiologically-based kinetic models: part 1. Development of a KNIME workflow to assist analogue selection for PBK modelling","volume":"29","author":"Thompson","year":"2024","journal-title":"Comput Toxicol"},{"issue":"12","key":"10.1016\/j.dmd.2026.100273_bib43","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1177\/0004867419877954","article-title":"A review of the antimicrobial side of antidepressants and its putative implications on the gut microbiome","volume":"53","author":"McGovern","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.dmd.2026.100273_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2023.1132127","article-title":"Antimicrobial activity of antidepressants on normal gut microbiota: results of the in vitro study","volume":"17","author":"Rukavishnikov","year":"2023","journal-title":"Front Behav Neurosci"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74934-9","article-title":"Unravelling the antimicrobial action of antidepressants on gut commensal microbes","volume":"10","author":"Ait Chait","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.dmd.2026.100273_bib46","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiol"},{"key":"10.1016\/j.dmd.2026.100273_bib47","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.envint.2018.07.046","article-title":"Antidepressant fluoxetine induces multiple antibiotics resistance in Escherichia coli via ROS-mediated mutagenesis","volume":"120","author":"Jin","year":"2018","journal-title":"Environ Int"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib48","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.2018901","article-title":"Combined exposure to non-antibiotic pharmaceutics and antibiotics in the gut synergistically promote the development of multi-drug-resistance in Escherichia coli","volume":"14","author":"Shi","year":"2022","journal-title":"Gut Microbes"},{"issue":"5","key":"10.1016\/j.dmd.2026.100273_bib49","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.3390\/ijms24054678","article-title":"Antimicrobial activity of sertraline on Listeria monocytogenes","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40709-015-0028-1","article-title":"Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance","volume":"22","author":"Ayaz","year":"2015","journal-title":"J Biol Res (Thessalon)"},{"issue":"8","key":"10.1016\/j.dmd.2026.100273_bib51","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nbt.3597","article-title":"Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking","volume":"34","author":"Wang","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"9","key":"10.1016\/j.dmd.2026.100273_bib52","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41592-020-0933-6","article-title":"Feature-based molecular networking in the GNPS analysis environment","volume":"17","author":"Nothias","year":"2020","journal-title":"Nat Methods"},{"issue":"2","key":"10.1016\/j.dmd.2026.100273_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/FPC.0000000000000392","article-title":"PharmGKB summary: sertraline pathway, pharmacokinetics","volume":"30","author":"Huddart","year":"2020","journal-title":"Pharmacogenet Genomics"},{"issue":"11","key":"10.1016\/j.dmd.2026.100273_bib54","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/FPC.0b013e328346063f","article-title":"PharmGKB summary: citalopram pharmacokinetics pathway","volume":"21","author":"Sangkuhl","year":"2011","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"10.1016\/j.dmd.2026.100273_bib55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/138920006775541561","article-title":"Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450","volume":"7","author":"Mandrioli","year":"2006","journal-title":"Curr Drug Metab"},{"issue":"9","key":"10.1016\/j.dmd.2026.100273_bib56","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00004583-200209000-00003","article-title":"Sertraline pharmacokinetics and dynamics in adolescents","volume":"41","author":"Axelson","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib57","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1038\/s41598-020-61362-y","article-title":"Sertraline induces DNA damage and cellular toxicity in Drosophila that can be ameliorated by antioxidants","volume":"10","author":"Jajoo","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.dmd.2026.100273_bib58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/antibiotics14010051","article-title":"Selective serotonin reuptake inhibitors: antimicrobial activity against ESKAPEE bacteria and mechanisms of action","volume":"14","author":"Endo","year":"2025","journal-title":"Antibiotics (Basel)"},{"issue":"40","key":"10.1016\/j.dmd.2026.100273_bib59","doi-asserted-by":"crossref","first-page":"14750","DOI":"10.1073\/pnas.0510828103","article-title":"Detoxification of superoxide without production of H2O2: antioxidant activity of superoxide reductase complexed with ferrocyanide","volume":"103","author":"Molina-Heredia","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.dmd.2026.100273_bib60","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1128\/jb.177.9.2305-2314.1995","article-title":"Lethal oxidative damage and mutagenesis are generated by iron in delta fur mutants of Escherichia coli: protective role of superoxide dismutase","volume":"177","author":"Touati","year":"1995","journal-title":"J Bacteriol"},{"issue":"4","key":"10.1016\/j.dmd.2026.100273_bib61","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/IAI.70.4.1889-1895.2002","article-title":"Inactivation of the Moraxella catarrhalis superoxide dismutase SodA induces constitutive expression of iron-repressible outer membrane proteins","volume":"70","author":"Luke","year":"2002","journal-title":"Infect Immun"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T10:14:53Z","timestamp":1779790493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626000425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0090955626000425"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100273","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbial resistance and metabolism of selective serotonin reuptake inhibitors drive multidrug resistance and contribute to antidepressant tachyphylaxis","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100273"}}